Glipizide Tablet
Product Images NDC 0591-0460

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 0591-0460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Glipizide, depicted as a molecular diagram showing characteristic rings and functional groups consistent with its chemical composition.*

FDA Label Image

Image 2

Glipizide Tablets, USP 5 mg tablet label from Actavis Pharma, Inc., with a quantity of 100 tablets. The label includes dosage information, storage instructions, and manufacturer details, along with a barcode and serialization coding area. It is marked Rx only and manufactured in India for Teva Pharmaceuticals USA.*

FDA Label Image

Image 3

Label for Glipizide Tablets, USP 10 mg, a drug for further processing by Actavis Pharma, Inc. The label includes a barcode, storage instructions to keep below 30°C, and mentions manufacturing by Watson Pharma Private Limited in India for Teva Pharmaceuticals USA. It states the package contains 100 tablets and has a prominent Teva logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.